Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
10/2003
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/07/2003US6630490 Purine derivative or analogue
10/07/2003US6630478 Administering to patient with drug-induced peripheral neuropathy an effective quantity of a purine derivative or analogue, a tetrahydroindolone derivative or analogue, or a pyrimidine derivative or analogue
10/07/2003US6630477 Therapeutic nucleoside compound
10/02/2003WO2003080613A1 Process for the preparation of intermediates in the synthesis of 2- (purin-9-yl) - tetrahydrofuran-3,4-diol derivatives
10/02/2003WO2003080610A1 Imidazopyridine derivatives as kinase inhibitors
10/02/2003WO2003080607A1 Novel alkoxypyridine-derivatives
10/02/2003US20030187263 Viricides
10/02/2003US20030187262 Viricides, anticancer agents
10/02/2003US20030187261 Purine derivatives, process for their preparation and use thereof
10/02/2003US20030187258 Bactericides
10/02/2003US20030187000 Hepatitis virus
10/02/2003US20030186999 Purine derivatives having, in particular, antiproliferative properties, and their biological uses
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003US20030186978 Novel telomerase inhibitors
10/02/2003US20030186924 Prodrugs
10/02/2003CA2480385A1 Alkoxypyridine derivatives as nitric oxide synthase inhibitors
10/01/2003EP1347975A1 Novel purine derivatives, preparation method and use as medicines
10/01/2003EP1242153B1 Method and device for capturing fine particles by trapping in a solid mixture of carbon dioxide snow type
10/01/2003EP1200435B1 Purine derivatives inhibitors of tyrosine protein kinase syk
09/2003
09/30/2003US6627645 Muscarinic agonists
09/30/2003US6627633 The compounds also are potent inhibitors of human cellular proliferation. As such, the compounds constitute pharmaceutical compositions with a pharmaceutically acceptable carrier. Such compounds are useful in inhibiting cellular
09/25/2003WO2003070738A3 Topiramate salts and compositions comprising and methods of making and using the same
09/25/2003US20030181471 Substituted (1,3-bis(cyclohexylmethyl)-1,2,3,6-tetrahydro-2,6-dioxo-9h-purin-8-YI)phenyl derivatives, their preparation and their use in the treatment of inflammatory conditions and immune disorders
09/24/2003EP1345929A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345928A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345927A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345926A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345925A2 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP1345922A1 Pyrazole compounds useful as protein kinase inhibitors
09/24/2003EP0920430B1 Purine derivatives and their use as anti-coagulants
09/24/2003CN1443764A New condensed tricyclonucleoside compound containing acyclovir fragment and its preparation method
09/24/2003CN1122040C Suger modified nucleosides and their use of synthesis of oligonucleotide
09/23/2003US6624309 Administering 4-heterocyclicbenzamide derivative
09/23/2003CA2073633C Use of xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas
09/18/2003WO2003075930A1 Synergistic enhancement of cognitive ability
09/18/2003US20030176699 Purine inhibitors of protein kinases, G proteins and polymerases
09/18/2003US20030176670 Multivalent macrolide antibiotics
09/18/2003US20030176419 As inhibitors of the retinoic acid-metabolism, as drugs
09/18/2003US20030176390 Methods of treating insulin resistance syndrome and diabetes
09/18/2003US20030175943 Biosynthesis of antitumor agents
09/17/2003EP0941099B1 Treatment of bronchitis with diuridine tetraphosphate
09/17/2003EP0702683B1 06-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells
09/17/2003CN1443191A Methods and compositions for treating hepatitis c virus
09/17/2003CN1443171A Novel heteroaryl derivatives and use thereof as pharmaceuticals
09/16/2003CA2238736C Novel a1 adenosine receptor agonists and antagonists
09/12/2003WO2003074508A1 Compounds and methods of treating cell proliferative diseases
09/12/2003CA2477003A1 Compounds and methods of treating cell proliferative diseases
09/11/2003US20030171583 Methods for the synthesis of substituted purines
09/11/2003US20030171385 Synergistic enhancement of cognitive ability
09/11/2003US20030171384 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
09/10/2003EP1023292B1 Process for the synthesis of chloropurine intermediates
09/10/2003CN1440970A ALkali condensation and phase transfer catalysis process synthesizing 6-benzylaminopurine
09/09/2003US6617331 Purine inhibitors of protein kinases, G proteins and polymerases
09/09/2003US6617324 Substituted pyrazoles as p38 kinase inhibitors
09/04/2003US20030166798 Mixtures of condensation polymers comprising organonitrogen or organosulfur polymers and curing agents, having preferential binding, used for analysis, separation and resolution of racemic mixtures
09/04/2003US20030166667 Potent ameliorating effect on dementia among the known BZ omega 3 receptor agonists and on learning and/or memory impairments induced by hypofunction of glutamatergic system or cholinergic system; Alzheimer's; cognition activators
09/04/2003US20030166581 Coadministered with caffeine, for prevention of seizures; for treatment of Parkinson's/Alzheimer's disease; dietetics; smoking cessation
09/03/2003EP1339754A1 Multicomponent compositions containing chitosan and methods of preparing same
09/03/2003CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/03/2003CN1440288A Heterocyclic compounds as inhibitors of enzyme DPP-IV
09/02/2003US6613936 Herpes and retroviral infections; diester derivatives of H2G bearing specific combinations of an amino acid ester and a fatty acid ester, improved oral bioavailability; 9-(2-(butyryloxymethyl)-4-(L-isoleucyloxy)butyl)guanine
09/02/2003US6613776 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease
08/2003
08/28/2003WO2003070738A2 Topiramate salts and compositions comprising and methods of making and using the same
08/28/2003WO2003051881B1 Substituted purine nucleoside libraries and compounds by solid-phase combinatorial strategies
08/28/2003US20030162968 1,4-Disubstituted benzo-fused urea compounds
08/28/2003US20030162802 Preferential enzyme inhibitors such as 2-((4-6-pyrimidinedion -2-yl)amino)-4-methyl-5-thiazolecarboxylic acid ethyl ester, used for prophylaxis of lymphocyte associated disorders
08/28/2003US20030162282 Such as 2-(t-butyldimethylsilyloxymethyl)-3,4-((dimethylmethylene)-dioxy)-5-hydroxy -tricyclo(5.2.1.02,6) deca-3,8-diene; for Diels-Alder reaction; antitumor agents
08/28/2003US20030162281 Intermediates and improved processes for the preparation of neplanocin A
08/28/2003CA2476422A1 Topiramate salts and compositions comprising and methods of making and using the same
08/27/2003EP1338595A2 Xanthine derivatives as DPP-IV inhibitors
08/27/2003EP1036794B1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
08/27/2003CN1439002A Muscarinic agonists
08/27/2003CN1438223A Method for preparing effective anti-virus cyclopropane derivative and intermediate used thereof
08/27/2003CN1119346C Benzothiadiaxoles and derivatives
08/26/2003US6610677 Enhancing glycogen synthesis, lowering blood levels of glucose, treating colon, ovarian, or breast cancer, treating diabetes, treating schizophrenia
08/26/2003US6610650 Modulation of cellular transcription factor activity
08/21/2003US20030158197 Certain alkylene diamine-substituted heterocycles
08/21/2003US20030158150 Combination therapy to treat hepatitis B virus
08/21/2003US20030157697 Intermediates and improved processes for the preparation of neplanocin A
08/21/2003US20030157052 Prodrug for in situ regeneration; water solubility
08/20/2003EP1335920A2 Small molecule compositions for binding to hsp90
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1035123B1 Novel heterocyclic compounds
08/20/2003EP0831829B1 Heterocyclic ring-fused pyrimidine derivatives
08/20/2003EP0799040B1 Trisubstituted thioxanthines
08/19/2003US6608069 Phenyl xanthine derivatives
08/19/2003CA2116967C Antidepressants
08/14/2003WO2003066622A1 Novel benzimidazole compounds
08/14/2003WO2003066586A2 Purine and isosteric antibacterial compounds
08/14/2003US20030153757 Synthesis and purification of valacyclovir
08/14/2003US20030153584 Such as cyclo-D-phenylglycyl-L-(2-(amino-3-mercaptobutanoic acid))
08/14/2003US20030153556 Anticoagulants and antiagglomerants
08/14/2003US20030153544 Fatty acid derivatives
08/14/2003CA2473724A1 Purine and isosteric antibacterial compounds
08/13/2003EP1334104A2 Methods for treatment of drug-induced peripheral neuropathy and related conditions
08/13/2003EP1334103A2 Methods for treatment of disease-induced peripheral neuropathy and related conditions
08/13/2003EP1242427B1 Novel piperidine and piperazine derivatives as p2x7 receptor antagonists
08/13/2003EP1147108B1 Substituted nitrogen heterocyclic derivatives and pharmaceutical use thereof
08/13/2003EP0814809B1 Aryl thioxanthines
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 120